Sharing a quick example from S. Korea that has a small US office in Irvine.
CG MedTech is a South Korean orthopedic startup based in Uijeongbu, Gyeonggi Province, focused on developing and manufacturing orthopedic implants and medical devices. The company is a subsidiary of CGBio, a regenerative medicine specialist, and has recently undergone a leadership transition with the appointment of Yu Hyun-seung as its new CEO. Yu, who also serves as the CEO of CGBio, brings extensive experience in biomaterials and regenerative medicine, having founded Bioalpha (CGBio’s predecessor) in 2000 and developed notable products like NOVOSIS, Korea’s first bone morphogenetic protein (BMP-2)-based bone substitute system for orthopedics, and Facetem, a calcium filler for wrinkle improvement.
CG MedTech’s core business includes its Resomet orthopedic implant line, which utilizes biodegradable magnesium alloy, a material that aligns with the growing trend of bioresorbable implants in orthopedics. The company aims to expand its portfolio by leveraging CGBio’s expertise in biomaterial technology, global distribution networks, and marketing capabilities. This strategic alliance is intended to position C...
